What is the extent of disparities in cancer clinical trials among low- and middle-income countries?
Peer-Reviewed Publication
Peer-Reviewed Publication
Latest News Releases
Updates every hour. Last Updated: 2-Nov-2025 02:11 ET (2-Nov-2025 07:11 GMT/UTC)
Peer-Reviewed Publication
20-Oct-2025
Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer
ECOG-ACRIN Cancer Research GroupReports and Proceedings
20-Oct-2025
Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer
NYU Langone Health / NYU Grossman School of MedicineReports and Proceedings
19-Oct-2025
ESMO: 10-year survival data for lung cancer immunotherapy, new PSMA-targeted therapy for recurrent prostate cancer, promising results in metastatic colorectal and urothelial cancers
University of California - Los Angeles Health SciencesReports and Proceedings
19-Oct-2025
New molecular map reveals how cells control traffic between the nucleus and cytoplasm
The Hebrew University of JerusalemPeer-Reviewed Publication
19-Oct-2025
ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma
University of Texas M. D. Anderson Cancer CenterPeer-Reviewed Publication
19-Oct-2025
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy
University of Texas M. D. Anderson Cancer CenterPeer-Reviewed Publication
19-Oct-2025
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer
University of FloridaReports and Proceedings
19-Oct-2025
Study finds protein target that predicts drug resistance in colon cancer
The Hebrew University of JerusalemPeer-Reviewed Publication
19-Oct-2025
Drug combo cuts risk of death in advanced prostate cancer by 40%
Cedars-Sinai Medical CenterPeer-Reviewed Publication